Old Web
English
Sign In
Acemap
>
Paper
>
Preclinical considerations for assessment of cellular & gene therapy products: FDA perspective
Preclinical considerations for assessment of cellular & gene therapy products: FDA perspective
2019
Gaya Hettiarachchi
Wei Liang
Keywords:
Bioinformatics
Genetic enhancement
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI
[]